Concepedia

Publication | Closed Access

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

342

Citations

23

References

2014

Year

Abstract

In this study, brivanib as adjuvant therapy to TACE did not improve OS.

References

YearCitations

Page 1